Comparative study of voltage-sensitive sodium channel blockers in focal ischaemia and electric convulsions in rodents.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Neuroscience Letters

• Publication date

  1994-05-19

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0304-3940(94)90652-1PMID 8084530
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The effect of lifarizine (RS‐87476), a novel sodium and calcium channel modulator, on ischaemic dopamine depletion in the corpus striatum of the gerbil

  1993cited by this paper
• Reduction of glutamate release and protection against ischemic brain damage by BW 1003C87.

  1992cited by this paper
• Pathophysiology and treatment of focal cerebral ischemia. Part I: Pathophysiology.

  1992cited by this paper
• Pathophysiology and treatment of focal cerebral ischemia. Part II: Mechanisms of damage and treatment.

  1992cited by this paper
• Cerebroprotective Effect of a Non–N‐Methyl‐D‐Aspartate Antagonist, GYKI 52466, After Focal Ischemia in the Rat

  1992cited by this paper
• Introducing NMDA antagonists into clinical practice: why head injury trials?

  1992cited by this paper
• Downregulation of sodium channels during anoxia: a putative survival strategy of turtle brain.

  1992cited by this paper
• Neurochemical and Behavioral Aspects of Lamotrigine

  1991cited by this paper
• The possible involvement of tetrodotoxin-sensitive ion channels in ischemic neuronal damage in the rat hippocampus.

  1991cited by this paper
• Neurocytotoxicity: pharmacological implications

  1991cited by this paper
• Ischemic brain damage: reduction by sodium-calcium ion channel modulator RS-87476.

  1991cited by this paper
• Coagulation factors and the increased risk of stroke in nonvalvular atrial fibrillation.

  1990cited by this paper
• Correlation between amino acid release and neuropathologic outcome in rat brain following middle cerebral artery occlusion.

  1990cited by this paper
• Cerebral hypoxia: some new approaches and unanswered questions

  1990cited by this paper
• Continuous lidocaine infusion and focal feline cerebral ischemia.

  1990cited by this paper
• Comparison of phenytoin with noncompetitive N-methyl-D-aspartate antagonists in a model of focal brain ischemia in rat.

  1990cited by this paper
• Changes in extracellular amino acid neurotransmitters produced by focal cerebral ischemia.

  1990cited by this paper
• Phenytoin protects against ischemia-produced neuronal cell death.

  1989cited by this paper
• Evidence for a common site of action of lidocaine and carbamazepine in voltage-dependent sodium channels.

  1989cited by this paper
• Glutamate neurotoxicity and diseases of the nervous system.

  1988cited by this paper
• The glutamate antagonist MK‐801 reduces focal ischemic brain damage in the rat

  1988cited by this paper
• Common modes of drug action on Na+ channels: local anesthetics, antiarrhythmics and anticonvulsants

  1987cited by this paper
• Pharmacological Studies on Lamotrigine, A Novel Potential Antiepileptic Drug

  1986cited by this paper
• Voltage clamp analysis of the inhibitory actions of diphenylhydantoin and carbamazepine on voltage-sensitive sodium channels in neuroblastoma cells.

  1985cited by this paper
• Magnesium gates glutamate-activated channels in mouse central neurones

  1984cited by this paper
• The Rat Brain in Stereotaxic Coordinates

  1983cited by this paper
• Focal Cerebral Ischaemia in the Rat: 1. Description of Technique and Early Neuropathological Consequences following Middle Cerebral Artery Occlusion

  1981cited by this paper
• Focal Cerebral Ischaemia in the Rat: 2. Regional Cerebral Blood Flow Determined by [14C]Iodoantipyrine Autoradiography following Middle Cerebral Artery Occlusion

  1981cited by this paper
• Brain Lesions, Obesity, and Other Disturbances in Mice Treated with Monosodium Glutamate

  1969cited by this paper
• The toxic effect of sodium L-glutamate on the inner layers of the retina.

  1957cited by this paper
• Comparative assays of antiepileptic drugs in mice and rats.

  1952cited by this paper
• A NEW SERIES OF ANTICONVULSANT DRUGS TESTED BY EXPERIMENTS ON ANIMALS

  1938cited by this paper

• Long-term protective effects of lamotrigine in a rat ovarian ischemia-reperfusion model.

  2024cites this paper
• Neuroprotective properties of antiepileptics: what are the implications for psychiatric disorders?

  2023cites this paper
• Thymoquinone Potentiates the Effect of Phenytoin against Electroshock-Induced Convulsions in Rats by Reducing the Hyperactivation of m-TOR Pathway and Neuroinflammation: Evidence from In Vivo, In Vitro and Computational Studies

  2021cites this paper
• Post-treatment with oxcarbazepine confers potent neuroprotection against transient global cerebral ischemic injury by activating Nrf2 defense pathway.

  2020cites this paper
• A Review of Neuroinflammatory Mechanisms in Ischemic Stroke: Background and Therapeutic Approaches

  2017cites this paper
• Phenytoin for neuroprotection.

  2016cites this paper
• AVANCES EN PSICOFARMACOLOGÍA Lamotrigina en psiquiatría

  2016cites this paper
• Phenytoin for neuroprotection.

  2016cites this paper
• EXPERIMENTAL FOCAL CEREBRAL ISCHEMIA

  2016cites this paper
• Neuroprotective agents in ischemic stroke: past failures and future opportunities

  2013cites this paper
• Lamotrigine blocks NMDA receptor-initiated arachidonic acid signalling in rat brain: implications for its efficacy in bipolar disorder.

  2012cites this paper
• ABORDAGEM AO PACIENTE NO TRAUMA: REVISÃO DE LITERATURA

  2011cites this paper
• Pharmacogenomics of Mood Stabilizers in the Treatment of Bipolar Disorder

  2010cites this paper
• Rapid quantification of lamotrigine in human plasma by two LC systems connected with tandem MS.

  2010cites this paper
• In vitro–in vivo correlation of modified release dosage form of lamotrigine

  2009cites this paper
• The maximal electroshock seizure (MES) model in the preclinical assessment of potential new antiepileptic drugs.

  2009cites this paper
• Synthesis of some novel N4-(naphtha[1,2-d]thiazol-2-yl)semicarbazides as potential anticonvulsants.

  2009cites this paper
• The sodium channel blocker RS100642 reverses down-regulation of the sodium channel α-subunit Nav 1.1 expression caused by transient ischemic brain injury in rats

  2009cites this paper
• Ultrastructure protection and attenuation of lipid peroxidation after blockade of presynaptic release of glutamate by lamotrigine in experimental spinal cord injury Laboratory investigation

  2008cites this paper
• A modelling approach to explore some hypotheses of the failure of neuroprotective trials in ischemic stroke patients.

  2008cites this paper
• Ultrastructure protection and attenuation of lipid peroxidation after blockade of presynaptic release of glutamate by lamotrigine in experimental spinal cord injury.

  2008cites this paper
• Neuroprotective Effect of Phenytoin and Hypothermia on a Spinal Cord Ischemic Injury Model in Rabbits

  2008cites this paper
• 토끼의 척수 허혈 손상 모델에서 페니토인과 저체온의 신경 보호 효과의 비교

  2008cites this paper
• [Neuroprotection in perinatal hypoxic-ischemic encephalopathy. Effective treatment and future perspectives].

  2007cites this paper
• Experimental focal cerebral ischemia

  2007cites this paper
• Acute Ischemic Stroke: Time, Penumbra, and Reperfusion

  2007cites this paper
• Optimizing therapy of seizures in stroke patients

  2006cites this paper
• Non-epilepsy uses of antiepileptic drugs

  2006cites this paper
• Estudo do efeito neuroprotetor da oxcarbazepina em culturas organotípicas de hipocampo à privação de oxigênio e glicose

  2006cites this paper
• Estudo do efeito neuroprotetor da oxcarbazepina em culturas organotípicas de hipocampo à privação de oxigênio e glicose

  2006cites this paper
• Non-epilepsy uses of antiepilepsy drugs.

  2006cites this paper
• Ion channel diseases of the central nervous system.

  2006cites this paper
• Neurochemical Underpinnings in Bipolar Disorder and Epilepsy

  2005cites this paper
• Antiepileptic drugs and neuroprotection: current status and future roles.

  2005cites this paper
• Treatment of Epilepsy: Focus on Levetiracetam

  2005cites this paper
• Neuroprotection — rationale for pharmacological modulation of Na+-channels

  2005cites this paper
• Neuroprotection: Where Are We Going?

  2005cites this paper
• Lamotrigine in the treatment of bipolar disorder

  2005cites this paper
• Antiepileptic Drug Treatment of Nonconvulsive Seizures Induced by Experimental Focal Brain Ischemia

  2004cites this paper
• Spotlight on Lamotrigine in Bipolar Disorder

  2004cites this paper
• Antiepileptic drugs in neuroprotection

  2004influential citation
• The search for neuroprotective strategies in stroke.

  2004cites this paper
• THE EFFECTS OF CITICOLINE AND LAMOTRIGINE ALONE AND IN COMBINATION FOLLOWING PERMANENT MIDDLE CEREBRAL ARTERY OCCLUSION IN RATS

  2004cites this paper
• Anti-epileptic drugs as possible neuroprotectants in cerebral ischemia.

  2003cites this paper
• Ionotropic glutamate receptors: still a target for neuroprotection in brain ischemia? Insights from in vitro studies.

  2003cites this paper
• Lamotrigine: a review of its use in bipolar disorder.

  2003cites this paper
• Antiepileptic Drugs and Apoptosis in the Developing Brain

  2003cites this paper
• Molecular pathways in cerebral ischemia

  2003cites this paper
• Neuroprotection assessment by topographic electroencephalographic analysis: effects of a sodium channel blocker to reduce polymorphic delta activity following ischaemic brain injury in rats

  2003cites this paper
• Vinpocetine for cognitive impairment and dementia.

  2003cites this paper
• Study of the Interaction of Lubeluzole with Cardiac Sodium Channels

  2003cites this paper
• Neuroprotective effects of the sodium channel blocker RS100642 and attenuation of ischemia-induced brain seizures in the rat.

  2002cites this paper
• Synthesis and biological evaluation of new 4-arylpiperidines and 4-aryl-4-piperidinols: dual Na+ and Ca2+ channel blockers with reduced affinity for dopamine D2 receptors

  2002cites this paper
• Halothane attenuates the cerebroprotective action of several Na+ and Ca2+ channel blockers via reversal of their ion channel blockade.

  2002cites this paper
• Antiepileptic drugs and apoptotic neurodegeneration in the developing brain

  2002cites this paper
• Synaptic, intracellular, and neuroprotective mechanisms of anticonvulsants: are they relevant for the treatment and course of bipolar disorders?

  2002cites this paper
• Sodium and Calcium Channel Blockers

  2002cites this paper
• Na+ channels and Ca2+ channels of the cell membrane as targets of neuroprotective substances.

  2002cites this paper
• Efficacy of current antiepileptics to prevent neurodegeneration in epilepsy models.

  2002cites this paper
• Molecular and Cellular Biology of Neuroprotection in the CNS

  2002influential citation
• Secondary injury mechanisms of spinal cord trauma: a novel therapeutic approach for the management of secondary pathophysiology with the sodium channel blocker riluzole.

  2002cites this paper
• Sodium and Calcium Channel Blockers

  2002cites this paper
• Regulation of interstitial excitatory amino acid concentrations after cortical contusion injury.

  2002cites this paper
• Synthesis and biological evaluation of new 4-arylpiperidines and 4-aryl-4-piperidinols: dual Na(+) and Ca(2+) channel blockers with reduced affinity for dopamine D(2) receptors.

  2002cites this paper
• Incorporation of sodium channel blocking and free radical scavenging activities into a single drug, AM‐36, results in profound inhibition of neuronal apoptosis

  2001cites this paper
• Investigation Of AM‐36: A Novel Neuroprotective Agent

  2001cites this paper
• Postischemic Intravenous Administration of Magnesium Sulfate Inhibits Hippocampal CA1 Neuronal Death after Transient Global Ischemia in Rats

  2001cites this paper
• Effective plasma concentration of a novel Na+/Ca2+ channel blocker NS-7 for its cerebroprotective actions in rats with a transient middle cerebral artery occlusion.

  2001cites this paper
• Chronic lamotrigine treatment increases rat hippocampal GABA shunt activity and elevates cerebral taurine levels.

  2001cites this paper
• Neuroprotective properties of 17β‐estradiol, progesterone, and raloxifene in MPTP C57Bl/6 mice

  2001cites this paper
• Evaluation of the neuroprotective effects of sodium channel blockers after spinal cord injury: improved behavioral and neuroanatomical recovery with riluzole.

  2001cites this paper
• Medicinal chemistry of neuronal voltage-gated sodium channel blockers.

  2001cites this paper
• Investigation of AM-36: a novel neuroprotective agent.

  2001cites this paper
• Neurotoxic/neuroprotective profile of carbamazepine, oxcarbazepine and two new putative antiepileptic drugs, BIA 2-093 and BIA 2-024.

  2000cites this paper
• Comparison of serum, cerebrospinal fluid and brain extracellular fluid pharmacokinetics of lamotrigine

  2000cites this paper
• Preferential inhibition by a novel Na(+)/Ca(2+) channel blocker NS-7 of severe to mild hypoxic injury in rat cerebrocortical slices: A possible involvement of a highly voltage-dependent blockade of Ca(2+) channel.

  2000cites this paper
• For ischemic brain damage, is preclinical evidence of neuroprotection by presynaptic blockade of glutamate release enough?

  2000cites this paper
• Thiopental combination treatments for cerebral resuscitation after prolonged cardiac arrest in dogs. Exploratory outcome study.

  2000cites this paper
• Broad-spectrum cation channel inhibition by LOE 908 MS reduces infarct volume in vivo and postmortem in focal cerebral ischemia in the rat.

  2000cites this paper
• Role Of Voltage‐Gated Na+ Channels In Hypoxia‐Induced Neuronal Injuries

  2000cites this paper
• Discovery of (2S)-1-(4-amino-2,3,5- trimethylphenoxy)-3-[4-[4-(4- fluorobenzyl)phenyl]-1-piperazinyl]-2-propanol dimethanesulfonate (SUN N8075): a dual Na(+) and Ca(2+) channel blocker with antioxidant activity.

  2000cites this paper
• The Emerging Neurobiology of Dissociative States

  2000cites this paper
• Rats Induced Middle Cerebral Artery Occlusion in Conscious − Damage After Endothelin-1 Delayed Treatment With AM-36 , a Novel Neuroprotective Agent , Reduces Neuronal

  1999cites this paper
• Limiting Neurological Damage After Stroke

  1999cites this paper
• Ischemic cell death in brain neurons.

  1999cites this paper
• Hippocampal cell loss in transient global cerebral ischemia in rats: a critical assessment.

  1999cites this paper
• Clinical trials with neuroprotective drugs in acute ischaemic stroke: are we doing the right thing?

  1999cites this paper
• Effects of hypothermia and lamotrigine on trace-conditioned learning after global cerebral ischemia in rabbits.

  1999cites this paper
• BIIR 561 CL: a novel combined antagonist of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors and voltage-dependent sodium channels with anticonvulsive and neuroprotective properties.

  1999cites this paper
• Delayed treatment with AM-36, a novel neuroprotective agent, reduces neuronal damage after endothelin-1-induced middle cerebral artery occlusion in conscious rats.

  1999cites this paper
• The role of excitotoxicity in neurodegenerative disease: implications for therapy.

  1999cites this paper
• The role of excitotoxicity in neurodegenerative disease: implications for therapy.

  1999cites this paper
• Nitric oxide in cerebral ischemic neurodegeneration and excitotoxicity.

  1998cites this paper
• Quantitative description of the voltage dependence of axonal excitability in human cutaneous afferents.

  1998cites this paper
• A novel Na+/Ca2+ channel blocker, NS-7, suppresses hypoxic injury in rat cerebrocortical slices

  1998cites this paper
• Sodium and potassium channel modulators: their role in neuroprotection.

  1997cites this paper
• Lamotrigine Inhibits Extracellular Glutamate Accumulation during Transient Global Cerebral Ischemia in Rabbits

  1997cites this paper
• Voltage‐Activated Calcium Channels: Targets of Antiepileptic Drug Therapy?

  1997cites this paper
• Altered Na(+)-channel function as an in vitro model of the ischemic penumbra: action of lubeluzole and other neuroprotective drugs.

  1997cites this paper
• Sodium channels and therapy of central nervous system diseases.

  1997cites this paper